SCHEMBL14075321

SCHEMBL14075321

CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(Oc3cccc(C(=O)O)c3)cc2C(=O)O)cc1

nearest known ligand 0.64

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.64
CYP1A2 P05177 1/20 0.64
ALDH1A1 P00352 2/20 0.62
BDKRB1 P46663 3/20 0.57
PLA2G7 Q13093 2/20 0.55
LMNA P02545 1/20 0.53
CYP2C19 P33261 1/20 0.53
KDM4E B2RXH2 1/20 0.50
HPGD P15428 1/20 0.50
CASP1 P29466 1/20 0.50
CASP7 P55210 1/20 0.50
HSD17B10 Q99714 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
MCL1 Q07820 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14075391 0.92 CYP2C9 (0.67) CYP2C9CYP1A2ALDH1A1BDKRB1PLA2G7
SCHEMBL14075327 0.89 CYP2C9 (0.67) CYP2C9CYP1A2ALDH1A1CYP2C19MCL1
SCHEMBL14075317 0.88 CYP2C9 (0.69) CYP2C9CYP1A2ALDH1A1CYP2C19MCL1
SCHEMBL14075311 0.87 ALDH1A1 (0.74) CYP2C9CYP1A2ALDH1A1LMNACYP2C19
SCHEMBL14075346 0.87 CYP2C9 (0.83) CYP2C9CYP1A2ALDH1A1LMNACYP2C19
SCHEMBL14075350 0.87 CYP2C9 (0.69) CYP2C9CYP1A2ALDH1A1CYP2C19MCL1
SCHEMBL14075400 0.85 CYP2C9 (0.65) CYP2C9CYP1A2ALDH1A1CYP2C19MCL1
SCHEMBL14087601 0.83 CYP2C9 (0.63) CYP2C9CYP1A2ALDH1A1CYP2C19MCL1
SCHEMBL14075324 0.82 KDM4E (0.65) CYP2C9CYP1A2ALDH1A1LMNACYP2C19
SCHEMBL14075353 0.82 CYP2C9 (0.61) CYP2C9CYP1A2ALDH1A1CYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429677-B2 Small molecule entry inhibitors TIBOTEC PHARMACEUTICALS LTD. (IE) 2008-09-30 US disclosed
US-7429677-B2 Small molecule entry inhibitors TIBOTEC PHARMACEUTICALS LTD. (IE) 2008-09-30 US disclosed